HSBC Holdings’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
Other funds holding NPCE
HSBC Holdings's NPCE Position: Q3 2026 in Review
HSBC Holdings sold out of Neuropace (NPCE) in Q3 2026, closing a stake of 26,033 shares — an estimated $420K sold.
HSBC Holdings first reported a position in NPCE in Q2 2025 and held it in 5 quarters. The position peaked at $661K in Q2 2025. 105 funds tracked by Wall St. Rank hold NPCE as of Q3 2026.
- HSBC Holdings reported no remaining Neuropace position as of Q3 2026 after selling out during the quarter.
- HSBC Holdings sold 26,033 Neuropace shares in Q3 2026, an estimated $420K.
- HSBC Holdings first reported a position in Neuropace in Q2 2025 and held it in 5 quarters.
- HSBC Holdings's Neuropace position peaked at $661K in Q2 2025.
- 105 funds tracked by Wall St. Rank held Neuropace as of Q3 2026.
Based on HSBC Holdings's 13F filing for Q3 2026, filed 16 Nov 2026.